Health Condition 1: I21- Acute myocardial infarction Health Condition 2: E11- Type 2 diabetes mellitus Health Condition 3: E889- Metabolic disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Newly diagnosed STEMI with Type 2 Diabetes mellitus (objective 1) Newly diagnosed STEMI with Stress Hyperglycaemia (objective 2) Willingness of patients to provide written informed consents
Exclusion criteria
Exclusion criteria: History of prior Acute Myocardial Infarction Type 1 diabetes or other types of diabetes including Gestational diabetes Hematologic disorders like polycythaemia, anaemia etc Severe renal dysfunction, kidney transplantation or chronic dialysis Severe hepatic dysfunction, serious infections, malignant tumours Pregnant or lactating Missing important laboratory data such as admission glucose or HbA1c
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Levels of short-term glycaemic control biomarkersTimepoint: Consecutive sample collection for 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| -Prevalence of of SH and T2DM in AMI patients -Correlation of biomarkers with with routine laboratory parameters and with clinical risk scores (GRACE Score and TIMI score)Timepoint: Consecutive sample collection for 3 years | — |
Countries
India
Contacts
Kasturba Medical College, Manipal